Lumida
/MAZE
⌘K
Maze Therapeutics Inc

Maze Therapeutics Inc

MAZE
$24.60USD-0.89%-0.22 today

MARKET CAP

1.4B

P/E (TTM)

FWD P/E

DAY RANGE

$24 – $26

52W RANGE

$20
$54

AI Summary

Stalk
TrimMedium

In Stage 4 decline, MAZE retains a medium-term bearish bias driven by recent Support Failure and Bearish Pivot Point patterns, with price trading below declining EMAs. Price now rests at a multi-touch support zone, making short-term timing unclear. Selling into resistance around the 9- and 20-day EMAs on a failed bounce is preferred over immediate execution.

  • 36% mean UACR reduction in Horizon Trial exceeds 30% threshold
  • MZE829 targets ~6 million US AMKD patients lacking approved therapy
  • Q2 2026 EPS of –$0.76 missed the –$0.70 estimate, underscoring losses
Full analysis →

Buying

10

institutions

Selling

5

institutions

New Positions

4

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY5.72 M170.56 M+2.58 M+31.0%0.04%
BI

Blackrock, Inc.

Q2 2026

BUY3.50 M104.52 M+932.42 K+36.2%0.00%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUYNEW2.60 M77.69 M+2.60 M+0.0%0.05%
FC

Farallon Capital Management, L.l.c.

Q2 2026

BUYNEW1.11 M33.06 M+1.11 M+0.0%0.15%
JC

Jpmorgan Chase & Co

Q2 2026

BUY964.01 K28.00 M+905.57 K+1551.1%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY874.88 K26.11 M+65.66 K+8.1%0.00%
CC

Casdin Capital, LLC

Q2 2026

BUY843.86 K25.18 M+85.00 K+11.2%1.26%
WP

Woodline Partners LP

Q2 2026

SELL736.22 K21.97 M+-564.24 K-43.4%0.07%
FC

Farallon Capital Management LLC

Q1 2026

BUYNEW373.00 K11.13 M+373.00 K+0.0%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY339.28 K10.12 M+289.18 K+577.0%0.47%
RI

Rtw Investments, LP

Q2 2026

BUYNEW212.00 K6.33 M+212.00 K+0.0%0.05%
AC

Aqr Capital Management LLC

Q2 2026

SELL27.16 K810.49 K+-784.00-2.8%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL20.19 K602.47 K+-440.96 K-95.6%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-29.89 K-100.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-15.80 K-100.0%0.00%